Insider Transactions in Q3 2021 at Stoke Therapeutics, Inc. (STOK)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2021
|
Huw M. Nash Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,700
-100.0%
|
$148,200
$26.0 P/Share
|
|
Sep 01
2021
|
Huw M. Nash Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,700
+50.0%
|
$11,400
$2.19 P/Share
|
|
Aug 02
2021
|
Huw M. Nash Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,700
-100.0%
|
$159,600
$28.87 P/Share
|
|
Aug 02
2021
|
Huw M. Nash Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,700
+50.0%
|
$11,400
$2.19 P/Share
|
|
Jul 13
2021
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
43,166
-12.68%
|
$1,424,478
$33.12 P/Share
|
|
Jul 01
2021
|
Huw M. Nash Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,700
-100.0%
|
$188,100
$33.33 P/Share
|
|
Jul 01
2021
|
Huw M. Nash Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,700
+50.0%
|
$11,400
$2.19 P/Share
|